Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Longhurst, J. G.
1997.
Cannabis and schizophrenia.
British Journal of Psychiatry,
Vol. 171,
Issue. 6,
p.
584.
Nixon, Sara Jo
Paul, Robert
and
Phillips, Mary
1998.
Cognitive Efficiency in Alcoholics and Polysubstance Abusers.
Alcoholism: Clinical and Experimental Research,
Vol. 22,
Issue. 7,
p.
1414.
Gournay , Professor Kevin
1998.
Dual diagnosis: mental health problems and substance abuse/dependence.
Mental Health Practice,
Vol. 2,
Issue. 3,
p.
28.
Sembhi, Sati
and
Lee, Joseph W.Y.
1999.
Cannabis Use in Psychotic Patients.
Australian & New Zealand Journal of Psychiatry,
Vol. 33,
Issue. 4,
p.
529.
Jo Nixon, Sara
1999.
Neurocognitive Performance in Alcoholics: Is Polysubstance Abuse Important?.
Psychological Science,
Vol. 10,
Issue. 3,
p.
181.
Alonso, R
Voutsinos, B
Fournier, M
Labie, C
Steinberg, R
Souilhac, J
Le Fur, G
and
Soubrié, P
1999.
Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function.
Neuroscience,
Vol. 91,
Issue. 2,
p.
607.
Sembhi, Sati
and
Lee, Joseph W.Y.
1999.
Cannabis Use in Psychotic Patients.
Australian & New Zealand Journal of Psychiatry,
Vol. 33,
Issue. 4,
p.
529.
Schuckit, Marc A.
2000.
Drug and Alcohol Abuse.
p.
174.
Kirby, M.Todd
Hampson, Robert E
and
Deadwyler, Sam A
2000.
Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus.
Brain Research,
Vol. 863,
Issue. 1-2,
p.
120.
Kavanagh, David J.
and
Mueser, Kim T.
2001.
The future of cognitive and behavioral therapies in the prevention and early management of psychosis: Opportunities and risks.
Behavior Therapy,
Vol. 32,
Issue. 4,
p.
693.
Fillit, Howard M.
Butler, Robert N.
O'Connell, Alan W.
Albert, Marilyn S.
Birren, James E.
Cotman, Carl W.
Greenough, William T.
Gold, Paul E.
Kramer, Arthur F.
Kuller, Lewis H.
Perls, Thomas T.
Sahagan, Barbara G.
and
Tully, Tim
2002.
Achieving and Maintaining Cognitive Vitality With Aging.
Mayo Clinic Proceedings,
Vol. 77,
Issue. 7,
p.
681.
Núñez, L. A.
and
Gurpegui, M.
2002.
Cannabis‐induced psychosis: a cross‐sectional comparison with acute schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 105,
Issue. 3,
p.
173.
Solowij, Nadia
and
Grenyer, Brin F. S.
2002.
Are the adverse consequences of cannabis use age‐dependent?.
Addiction,
Vol. 97,
Issue. 9,
p.
1083.
Müller-Vahl, Kirsten R
Prevedel, Heidrun
Theloe, Karen
Kolbe, Hans
Emrich, Hinderk M
and
Schneider, Udo
2003.
Treatment of Tourette Syndrome with Delta-9-Tetrahydrocannabinol (Δ9-THC): No Influence on Neuropsychological Performance.
Neuropsychopharmacology,
Vol. 28,
Issue. 2,
p.
384.
Verdoux, Hélène
Sorbara, F
Gindre, C
Swendsen, Joël D
and
van Os, Jim
2003.
Cannabis use and dimensions of psychosis in a nonclinical population of female subjects.
Schizophrenia Research,
Vol. 59,
Issue. 1,
p.
77.
Fergusson, D.M
Swain-Campbell, N.R
and
Horwood, L.J
2003.
Arrests and convictions for cannabis related offences in a New Zealand birth cohort.
Drug and Alcohol Dependence,
Vol. 70,
Issue. 1,
p.
53.
Fergusson, David M.
Horwood, L. John
and
Beautrais, Annette L.
2003.
Cannabis and educational achievement.
Addiction,
Vol. 98,
Issue. 12,
p.
1681.
Patel, Sachin
and
Hillard, Cecilia J.
2003.
Cannabinoid-induced Fos expression within A10 dopaminergic neurons.
Brain Research,
Vol. 963,
Issue. 1-2,
p.
15.
Cairney, Sheree
Clough, Alan R
Maruff, Paul
Collie, Alex
Currie, Bart J
and
Currie, Jon
2003.
Saccade and Cognitive Function in Chronic Kava Users.
Neuropsychopharmacology,
Vol. 28,
Issue. 2,
p.
389.
Llorca, P.-M
Chereau, I
Brousse, G
and
Schawn, R
2004.
Troubles psychiatriques d'origine toxique ou alimentaire.
EMC - Psychiatrie,
Vol. 1,
Issue. 3,
p.
188.
eLetters
No eLetters have been published for this article.